Publication:
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

dc.contributor.authorAmin Gasmien_US
dc.contributor.authorSadaf Nooren_US
dc.contributor.authorTorsak Tippairoteen_US
dc.contributor.authorMaryam Dadaren_US
dc.contributor.authorAlain Menzelen_US
dc.contributor.authorGeir Bjørklunden_US
dc.contributor.otherCouncil for Nutritional and Environmental Medicineen_US
dc.contributor.otherRazi Vaccine & Serum Research Institute, Iranen_US
dc.contributor.otherLaboratoires Reunis Kutter-Lieners-Hastert Centre Langwiesen_US
dc.contributor.otherBahauddin Zakariya Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherSociété Francophone de Nutrithérapie et de Nutrigénétique Appliquéeen_US
dc.contributor.otherBBH Hospitalen_US
dc.date.accessioned2020-06-02T04:42:55Z
dc.date.available2020-06-02T04:42:55Z
dc.date.issued2020-06-01en_US
dc.description.abstract© 2020 Elsevier Inc. It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.en_US
dc.identifier.citationClinical Immunology. Vol.215, (2020)en_US
dc.identifier.doi10.1016/j.clim.2020.108409en_US
dc.identifier.issn15217035en_US
dc.identifier.issn15216616en_US
dc.identifier.other2-s2.0-85084738239en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/56202
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084738239&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleIndividual risk management strategy and potential therapeutic options for the COVID-19 pandemicen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084738239&origin=inwarden_US

Files

Collections